Surgical Management of Hepatocellular Carcinoma: Resection or Transplantation?

被引：49

作者：

Philosophe B. ^{[1
]}

Greig P.D. ^{[1
]}

Hemming A.W. ^{[1
]}

Cattral M.S. ^{[1
]}

Wanless I. ^{[1
]}

Rasul I. ^{[1
]}

Baxter N. ^{[1
]}

Taylor B.R. ^{[1
]}

Langer B. ^{[1
,2
]}

机构：

[1] Department of Surgery, University of Toronto, Toronto Hospital, Toronto, Ont.

[2] Toronto Hospital, Toronto, Ont. M5G 2C4, en 9-242

来源：

Journal of Gastrointestinal Surgery | 1998年 / 2卷 / 1期

关键词：

Hepatocellular Carcinoma; Liver Transplantation; Liver Resection; Hepatic Resection; Vascular Invasion;

D O I：

10.1016/S1091-255X(98)80099-1

中图分类号：

学科分类号：

摘要：

Liver resection or transplantation offers the best opportunity for cure of hepatocellular carcinoma (HCC). To determine the relative roles for resection and transplantation and to evaluate the patient and tumor characteristics that might predict survival, the records of 125 patients treated for nonfibrolamellar HCC at The Toronto Hospital between 1981 and 1996 were reviewed. No adjuvant chemotherapy or antiviral protocols were used. Resection was the first operation in 67 patients; one underwent re-resection. Sixty patients underwent transplantation including two who had previously had a resection; 40 had known or suspected HCC and 20 had incidental tumors identified in the explanted liver. The incidence of cirrhosis was 49% for resection and 88% for transplantation. The incidence of hepatitis B virus (HBV) was 58% and 33%, respectively. The operative mortality rate for resection was 4.4% (9.4% in cirrhotic and 0 in noncirrhotic patients) and 13.3% for transplantation. The 5-year cumulative recurrence rate was 55% following resection and 20% following transplantation (P <0.001). The 5-year Kaplan-Meier survival rates were 38% for resection and 45% for transplantation - 60% for transplanted HBV-negative and 17% for HBV-positive patients (P <0.001). After resection, recurrent HCC accounted for 86% of deaths, whereas recurrent HBV was responsible for 42% of deaths after transplantation. By univariate analysis, following resection, vascular invasion, advanced stage, multiple tumors, and lack of a capsule were predictive of survival; cirrhosis, HBV, age, tumor size, number, and grade were not. By multivariate analysis, only vascular invasion was predictive for resection and HBV for transplantation. Resection and transplantation are complementary methods of treating HCC. With the current organ shortage, resection should be considered first-line treatment. HBV-positive patients with HCC should only undergo transplantation in combination with effective antiviral therapy.

引用

页码：21 / 27

页数：6

共 30 条

[1]

Okuda K., Hepatocellular carcinoma: Recent progress, Hepatology, 15, pp. 948-963, (1992)

[2]

Busitil R.W., Farmer D.G., The surgical treatment of primary hepatobiliary malignancy, Liver Transplant Surg, 2, pp. 114-130, (1996)

[3]

Ringe B., Pichlmayr R., Wittekind C., Tusch G., Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients, World J Surg, 15, pp. 270-285, (1991)

[4]

Kumada T., Nakano S., Takeda I., Et al., Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma, Hepatology, 25, pp. 87-92, (1997)

[5]

Adachi E., Maeda T., Matsamata T., Et al., Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma, Gastroenterology, 108, pp. 768-775, (1995)

[6]

Mazzaferro V., Regalia E., Doci R., Et al., Liver transplantation for the treatment of small hepatocellular carinomas in patients with cirrhosis, N Engl J Med, 334, pp. 393-399, (1996)

[7]

Beahrs O.H., Henson D.E., Hutter R.V.D., Kennedy B.J., Manual for Staging of Cancer, pp. 89-91, (1992)

[8]

Edmondson H.A., Steiner P.E., Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies, Cancer, 7, pp. 462-503, (1954)

[9]

Foster J.H., Herman M.M., Solid liver tumors, Major Problems in Clinical Surgery, (1977)

[10]

Franco D., Capussotti L., Smadja C., Et al., Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis, Gastroenterology, 98, pp. 733-738, (1990)

← 1 2 3 →